Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37140610)

  • 21. Association between preoperative C-reactive protein level and colorectal cancer survival: a meta-analysis.
    Woo HD; Kim K; Kim J
    Cancer Causes Control; 2015 Nov; 26(11):1661-70. PubMed ID: 26376895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative systemic inflammation and infectious complications after resection of colorectal liver metastases.
    Neal CP; Mann CD; Garcea G; Briggs CD; Dennison AR; Berry DP
    Arch Surg; 2011 Apr; 146(4):471-8. PubMed ID: 21502458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Negative impact of surgical site infection on long-term outcomes after hepatic resection for colorectal liver metastases.
    Haruki K; Shiba H; Fujiwara Y; Furukawa K; Wakiyama S; Ogawa M; Ishida Y; Misawa T; Yanaga K
    Anticancer Res; 2013 Apr; 33(4):1697-703. PubMed ID: 23564818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Value of the Glasgow Prognostic Score or Modified Glasgow Prognostic Score for Patients with Colorectal Cancer Receiving Various Treatments: a Systematic Review and Meta-Analysis.
    He L; Li H; Cai J; Chen L; Yao J; Zhang Y; Xu W; Geng L; Yang M; Chen P; Zheng J; Yang Y; Gong S
    Cell Physiol Biochem; 2018; 51(3):1237-1249. PubMed ID: 30481755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Prognostic Significance of C-reactive Protein-To-Lymphocyte Ratio in Colorectal Liver Metastases.
    Taniai T; Haruki K; Hamura R; Fujiwara Y; Furukawa K; Gocho T; Shiba H; Yanaga K
    J Surg Res; 2021 Feb; 258():414-421. PubMed ID: 33109402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits of Laparoscopic Approach for Resection of Liver Tumors in Cirrhotic Patients.
    Le Roux F; Rebibo L; Cosse C; Chatelain D; Nguyen-Khac E; Badaoui R; Regimbeau JM
    J Laparoendosc Adv Surg Tech A; 2018 May; 28(5):553-561. PubMed ID: 29350570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of patient, primary tumor and metastatic pattern including tumor location on survival in patients undergoing ablation or resection for colorectal liver metastases: A population-based national cohort study.
    Scherman P; Syk I; Holmberg E; Naredi P; Rizell M
    Eur J Surg Oncol; 2021 Feb; 47(2):375-383. PubMed ID: 32828581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term and perioperative outcomes of laparoscopic versus open liver resection for colorectal liver metastases with propensity score matching: a multi-institutional Japanese study.
    Beppu T; Wakabayashi G; Hasegawa K; Gotohda N; Mizuguchi T; Takahashi Y; Hirokawa F; Taniai N; Watanabe M; Katou M; Nagano H; Honda G; Baba H; Kokudo N; Konishi M; Hirata K; Yamamoto M; Uchiyama K; Uchida E; Kusachi S; Kubota K; Mori M; Takahashi K; Kikuchi K; Miyata H; Takahara T; Nakamura M; Kaneko H; Yamaue H; Miyazaki M; Takada T
    J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):711-20. PubMed ID: 25902703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Impact of Combined Modified Glasgow Prognostic Score and C-Reactive Protein/Albumin Ratio in Patients with Colorectal Cancer.
    Son W; Shin SJ; Park SH; Lee SK; Park EJ; Baik SH; Lee KY; Kang J
    Diagnostics (Basel); 2020 Oct; 10(11):. PubMed ID: 33105743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancers.
    Nagayama S; Hasegawa S; Hida K; Kawada K; Hatano E; Nakamura K; Seo S; Taura K; Yasuchika K; Matsuo T; Zaima M; Kanazawa A; Terajima H; Tada M; Adachi Y; Nishitai R; Manaka D; Yoshimura T; Doi K; Horimatsu T; Mitsuyoshi A; Yoshimura K; Niimi M; Matsumoto S; Sakai Y; Uemoto S
    Int J Clin Oncol; 2017 Apr; 22(2):316-323. PubMed ID: 27752787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nomograms predicting primary lymph node metastases and prognosis for synchronous colorectal liver metastasis with simultaneous resection of colorectal cancer and liver metastases.
    Yao J; Chen Q; Deng Y; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Zhao H; Cai J
    Ann Palliat Med; 2021 Apr; 10(4):4220-4231. PubMed ID: 33832313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammation-based prognostic scores in geriatric patients with rectal cancer.
    Manoglu B; Sokmen S; Bisgin T; Semiz HS; Görken IB; Ellidokuz H
    Tech Coloproctol; 2023 May; 27(5):397-405. PubMed ID: 36197565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer.
    Leitch EF; Chakrabarti M; Crozier JE; McKee RF; Anderson JH; Horgan PG; McMillan DC
    Br J Cancer; 2007 Nov; 97(9):1266-70. PubMed ID: 17923866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glasgow Prognostic Score (GPS) can be a useful indicator to determine prognosis of patients with colorectal carcinoma.
    Nozoe T; Matono R; Ijichi H; Ohga T; Ezaki T
    Int Surg; 2014; 99(5):512-7. PubMed ID: 25216413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nomograms incorporating preoperative RDW level for the prediction of postoperative complications and survival in colorectal liver metastases after resection.
    Chen Q; Mao R; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Zhao H; Cai J
    Ann Palliat Med; 2021 Apr; 10(4):4143-4158. PubMed ID: 33832316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The C-reactive protein to albumin ratio is an excellent prognostic predictor for gallbladder cancer.
    Bao Y; Yang J; Duan Y; Chen Y; Chen W; Sun D
    Biosci Trends; 2021 Jan; 14(6):428-435. PubMed ID: 33239498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of the Best Prognostic Marker Among Immunonutritional Parameters Using Serum C-Reactive Protein and Albumin in Non-Small Cell Lung Cancer.
    Matsubara T; Takamori S; Haratake N; Fujishita T; Toyozawa R; Ito K; Shimokawa M; Yamaguchi M; Seto T; Okamoto T
    Ann Surg Oncol; 2021 Jun; 28(6):3046-3054. PubMed ID: 33084992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
    Margonis GA; Buettner S; Andreatos N; Wagner D; Sasaki K; Galjart B; Kamphues C; Pawlik TM; Poultsides G; Kaczirek K; Lønning PE; Verhoef C; Kreis ME; Wolfgang CL; Weiss MJ
    J Surg Oncol; 2018 Dec; 118(7):1074-1080. PubMed ID: 30261094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic review and meta-analysis comparing the short- and long-term outcomes for laparoscopic and open liver resections for liver metastases from colorectal cancer.
    Ciria R; Ocaña S; Gomez-Luque I; Cipriani F; Halls M; Fretland ÅA; Okuda Y; Aroori S; Briceño J; Aldrighetti L; Edwin B; Hilal MA
    Surg Endosc; 2020 Jan; 34(1):349-360. PubMed ID: 30989374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
    Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
    Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.